The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study
Abstract
Twenty-one consecutive patients with streptococcal toxic shock syndrome (TSS) between December 1994 and April 1995 were treated with a median dose of 2 g of intravenous immunoglobulin (IVIG)/kg (cases) and were compared with 32 patients with streptococcal TSS between 1992 and 1995 who did not receive IVIG therapy (controls). The outcome measure was 30-day survival. Patient plasma was tested for its ability to inhibit T cell activation induced by the infecting strain. The proportion of cases with 30-day survival was higher than that of the controls with 30-day survival (67% vs. 34%, respectively; P = .02). Multivariate analysis revealed that IVIG administration and a lower Acute Physiology and Chronic Health Evaluation II score were associated with survival; the odds ratio for survival associated with IVIG therapy was 8.1 (95% confidence interval, 1.6-45; P = .009). IVIG therapy enhanced the ability of patient plasma to neutralize bacterial mitogenicity and reduced T cell production of interleukin-6 and tumor necrosis factor alpha. IVIG may be an effective adjunctive therapy for streptococcal TSS, possibly because of its ability to neutralize bacterial exotoxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,176
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 3,409
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Chambers, J., Hastie, T., & Pregibon, D. (1990) · Compstat · doi:10.1007/978-3-642-50096-1_48 · Cited by 1,742
Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Manual of Clinical Microbiology
BALOWS, A., HAUSLER Jr., W. J., HERRMANN, K. L., ISENBERG, H. D., & SHADOMY, H. J. (1991) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651991000600015 · Cited by 1,131
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Invasive Group A Streptococcal Infections in Ontario, Canada
Davies, H. D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. E., & Low, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350803 · Cited by 736
Self-citationStevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473
Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin Procedure
Sander, B., Andersson, J., & Andersson, U. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00578.x · Cited by 452
The Serological Classification of Streptococcus pyogenes
Griffith, F. (1934) · Epidemiology and Infection · doi:10.1017/s0022172400043308 · Cited by 318
Aspects of Pathogenesis of Serious Group A Streptococcal Infections in Sweden, 1988-1989
Holm, S. E., Norrby, A., Bergholm, A.-M., & Norgren, M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.1.31 · Cited by 302
Bacterial pyrogenic exotoxins as superantigens
Kotb, M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.3.411 · Cited by 282
Self-citationFailure of Intensive Care Unit Support to Influence Mortality From Pneumococcal Bacteremia
Hook, E. W. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330320053032 · Cited by 262
Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991
Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F., Walmsley, S., & Low, D. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.792 · Cited by 251
Self-citationIntravenous Immunoglobulin Therapy for Toxic Shock Syndrome
Barry, W. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480240077038 · Cited by 248
Talkington, D. F., Schwartz, B., Black, C. M., Todd, J. K., Elliott, J., Breiman, R. F., & Facklam, R. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3369-3374.1993 · Cited by 195
Self-citationNorrby-Teglund, A., Kaul, R., Low, D. E., McGeer, A., Newton, D. W., Andersson, J., Andersson, U., & Kotb, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.3057 · Cited by 182
Self-citationLamothe, F., DʼAmico, P., Ghosn, P., Tremblay, C. L., Braidy, J., & Patenaude, J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1469 · Cited by 129
Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
Norrby‐Teglund, A., Newton, D. W., Kotb, M., Holm, S. E., & Norgren, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5227-5233.1994 · Cited by 125
Self-citationCook, E. F., & Goldman, L. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90036-x · Cited by 114
Norrby‐Teglund, A., Basma, H., Andersson, J., McGeer, A., Low, D. E., & Kotb, M. (1998) · Clinical Infectious Diseases · doi:10.1086/514588 · Cited by 100
Self-citationNorrby‐Teglund, A., Norgren, M., Holm, S. E., Andersson, J., & Andersson, J. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3731-3738.1994 · Cited by 76
Self-citationPérez, C. M., Kubak, B., Cryer, H., Salehmugodam, S., Vespa, P., & Farmer, D. G. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00304-x · Cited by 70
Musser, J. M., Gray, B. M., Schlievert, P. M., & Pichichero, M. E. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.600-603.1992 · Cited by 57
Aukrust, P., Hestdal, K., Lien, E., Bjerkeli, V., Nordøy, I., Espevik, T., Müller, F., & Frøland, S. S. (1997) · The Journal of Infectious Diseases · doi:10.1086/516510 · Cited by 18
Empiricism and Wegener's Granulomatosis
DeRemee, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350113 · Cited by 11
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Pathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
Metadata
- Authors
- Kaul, R., McGeer, A., Norrby‐Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K., Talbot, J., Low, D. E., & The Canadian Streptococcal Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04
- Volume
- 28
- Issue
- 4
- Pages
- 800-807
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2013760221
- Cited by
- 544
- References
- 29
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.